周围假肢骨解:机制和潜在的治疗策略
Fang Yao1, Yue Bao2, Qian Meng3
1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China.
Cellular signalling
|March 25, 2025
概括
周围假肢骨解,部植入物后的骨损失障碍,是由导致炎症的磨损颗粒驱动的. 自然化合物,ncRNAs,外体和非PPO药物在调节骨质稳定和治疗这种疾病方面表现有前途.
科学领域:
- 生物医学工程 生物医学工程
- 整形外科 整形外科 整形外科
- 细胞生物学 细胞生物学
背景情况:
- 周围假肢骨质溶解是关节整形术后的常见并发症,其特点是植入物周围的骨损失.
- 植入物磨损颗粒诱导机械应激,炎症和氧化应激,破坏骨细胞平衡 (骨质细胞和骨质细胞).
研究的目的:
- 系统地审查周围假肢骨质溶解的致病机制.
- 探索涉及自然产品,非编码RNAs (ncRNAs),外体和非PPO药物的治疗治疗围围假肢骨解的治疗策略.
主要方法:
- 对周围假肢骨解的致病机制和治疗干预措施的文献综述.
- 分析调节骨稳态和细胞功能的分子通路.
主要成果:
- 磨损颗粒引发炎症和氧化应激反应,导致骨再吸收.
- 中原先类黄,miR-19a-3p,干细胞衍生的外体和某些非PPO药物表明对骨质稳定有调节作用.
- 这些药物调节炎症级联,氧化应激和组织再生,以抑制骨解.
结论:
- 了解周围假肢骨质溶解的分子病变是开发有效治疗方法的关键.
- 自然化合物,ncRNA,外体和非PPO药物为周围假肢骨解提供了有前途的治疗途径.
- 这一审查为未来针对围围假肢骨解的药物开发提供了基础.
更多相关视频
07:35Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
Published on: April 11, 2012
17.4K
04:13Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
256
相关概念视频
Fractures: Bone Repair
2.8K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.8K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
